FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022132999> ?p ?o ?g. }

• W2022132999 abstract "In our quest to design topoisomerase II targeting drugs having high CNS uptake we have developed a unique subclass of anthracyclines typified by berubicin (WP744, RTA 744) now in clinical trials. Our subsequent efforts were directed at identifying orally bioavailable inhibitors of this class such as WP769, a novel anthracycline with unique properties. In addition to its ability to circumvent P‐gp and MRP1‐mediated efflux and cross the blood‐brain barrier (BBB), WP769 has been synthesized to have enhanced oral bioavailability. To determine the bioavailability, pharmacokinetics and tissue distribution of different WP769 formulations, CD 1 mice (M, 50 gm) were administered WP769 as an IV bolus via the tail vein (0.1 ml; vehicle, DMSO:D5W, 5:95, v/v) and by oral gavage (0.2 ml; vehicles cyclodextrin (C) or microemulsion (ME)). Blood samples were collected in heparinized tubes (5 animal per time point) prior to and at selected time points between 5 min and 48 hrs after drug administration. Tissue samples were harvested, washed and weighed using the identical collection schedule. WP769 was extracted from solid tissue samples using a liquid‐liquid extraction method, while solid phase extraction was used for blood samples. All samples were analyzed by LC/MS/MS using electrospray ionization operating in positive ion mode. This method has an LLQ of 0.5 ng/ml and is linear throughout a dynamic range of 0.5 ng/ml to 1.5 g/ml. PK parameters describing WP769 disposition were determined by fitting non‐compartmental models to the mean plasma/brain concentration‐time data. Bioavailability was determined by direct comparison between the AUCs achieved with oral and intravenous administration. Tissue concentration is expressed as ng/g. Mean peak plasma concentrations for IV was 510 ± 83.7 ng/ml vs. 225 ± 124.8 ng/ml (ME) and 96 ng/ml (C). Oral absorption was rapid with peak concentration occurring within 2 hrs of oral administration. Mean distribution volume (Vd), half‐life (t1/2), and drug clearance (Cl) for intravenous WP769 were 87 L/kg, 6.4 hrs, and 8.4 L/hr/kg. Apparent oral PK parameters were as follows (ME vs C): Vd (237 vs 174), t1/2 (8.6 vs 6.9), Cl (19.2 vs 17.6)WP769 rapidly distributed to all tissues examined, regardless of administration route. Oral bioavailability (ME vs C) was 44% vs 48%, with the ratio of iv:oral peak and terminal plasma concentration for the ME for was 3.4:1 and 1.2:1, respectively. Of extreme interest was the ability of WP769 to penetrate the BBB and maintain high concentrations for an extended period of time. Mean peak concentrations in the CNS were 220.6 ± 11.3 ng/g and 221.6 ± 40.3 ng/g for intravenous and oral administration (ME). Drug persisted in the CNS with WP769 being measurable 48 hours after a single oral dose, where the CNS concentration was > 20‐fold higher in the ME treated group. WP769 is an anthracycline with exceptional characteristics including enhanced cytotoxicity, the ability to avoid cellular resistance mechanisms, oral bioavailability, and the capacity to penetrate the CNS suggesting unique roles for this agent in the treatment of CNS leukemias, solid tumors, and metastases. Citation Information: Mol Cancer Ther 2009;8(12 Suppl):C214." @default.
• W2022132999 created "2016-06-24" @default.
• W2022132999 creator A5016121227 @default.
• W2022132999 creator A5029507102 @default.
• W2022132999 creator A5055645760 @default.
• W2022132999 creator A5062959791 @default.
• W2022132999 creator A5067023859 @default.
• W2022132999 creator A5086839893 @default.
• W2022132999 date "2009-12-10" @default.
• W2022132999 modified "2023-09-27" @default.
• W2022132999 title "Abstract C214: WP769, an orally bioavailable blood‐brain barrier penetrating anthracycline" @default.
• W2022132999 doi "https://doi.org/10.1158/1535-7163.targ-09-c214" @default.
• W2022132999 hasPublicationYear "2009" @default.
• W2022132999 type Work @default.
• W2022132999 sameAs 2022132999 @default.
• W2022132999 citedByCount "0" @default.
• W2022132999 crossrefType "proceedings-article" @default.
• W2022132999 hasAuthorship W2022132999A5016121227 @default.
• W2022132999 hasAuthorship W2022132999A5029507102 @default.
• W2022132999 hasAuthorship W2022132999A5055645760 @default.
• W2022132999 hasAuthorship W2022132999A5062959791 @default.
• W2022132999 hasAuthorship W2022132999A5067023859 @default.
• W2022132999 hasAuthorship W2022132999A5086839893 @default.
• W2022132999 hasConcept C112705442 @default.
• W2022132999 hasConcept C181389837 @default.
• W2022132999 hasConcept C185592680 @default.
• W2022132999 hasConcept C2777056448 @default.
• W2022132999 hasConcept C43617362 @default.
• W2022132999 hasConcept C71924100 @default.
• W2022132999 hasConcept C98274493 @default.
• W2022132999 hasConceptScore W2022132999C112705442 @default.
• W2022132999 hasConceptScore W2022132999C181389837 @default.
• W2022132999 hasConceptScore W2022132999C185592680 @default.
• W2022132999 hasConceptScore W2022132999C2777056448 @default.
• W2022132999 hasConceptScore W2022132999C43617362 @default.
• W2022132999 hasConceptScore W2022132999C71924100 @default.
• W2022132999 hasConceptScore W2022132999C98274493 @default.
• W2022132999 hasLocation W20221329991 @default.
• W2022132999 hasOpenAccess W2022132999 @default.
• W2022132999 hasPrimaryLocation W20221329991 @default.
• W2022132999 hasRelatedWork W1769524126 @default.
• W2022132999 hasRelatedWork W1773267112 @default.
• W2022132999 hasRelatedWork W1990241289 @default.
• W2022132999 hasRelatedWork W2009860565 @default.
• W2022132999 hasRelatedWork W2017842000 @default.
• W2022132999 hasRelatedWork W2018545751 @default.
• W2022132999 hasRelatedWork W2023740387 @default.
• W2022132999 hasRelatedWork W2032244228 @default.
• W2022132999 hasRelatedWork W2046878103 @default.
• W2022132999 hasRelatedWork W2158582055 @default.
• W2022132999 hasRelatedWork W2171508892 @default.
• W2022132999 hasRelatedWork W2237277179 @default.
• W2022132999 hasRelatedWork W2350190568 @default.
• W2022132999 hasRelatedWork W2362864664 @default.
• W2022132999 hasRelatedWork W2389625139 @default.
• W2022132999 hasRelatedWork W2726895853 @default.
• W2022132999 hasRelatedWork W3088527826 @default.
• W2022132999 hasRelatedWork W3209881455 @default.
• W2022132999 hasRelatedWork W2179142149 @default.
• W2022132999 hasRelatedWork W2510753650 @default.
• W2022132999 isParatext "false" @default.
• W2022132999 isRetracted "false" @default.
• W2022132999 magId "2022132999" @default.
• W2022132999 workType "article" @default.